AVAXIM 160U 160 U ANTIGENICE injection suspension SANOFI
Active substance: inactivated hepatitis A vaccine
J07BC02 Antiinfectives for systemic use | Viral vaccines | Hepatitis vaccines
Indicated for: prevention of hepatitis A
Find medicines for human use by name or active substance.
Browse by initial
2,041–2,060 of 2,168 medicines
Active substance: inactivated hepatitis A vaccine
J07BC02 Antiinfectives for systemic use | Viral vaccines | Hepatitis vaccines
Indicated for: prevention of hepatitis A
Active substance: hepatitis A vaccine inactivated adsorbed
J07BC02 Antiinfectives for systemic use | Viral vaccines | Hepatitis vaccines
Indicated for: prevention of hepatitis A
Active substance: hepatitis A vaccine inactivated adsorbed
J07BC02 Antiinfectives for systemic use | Viral vaccines | Hepatitis vaccines
Indicated for: prevention of hepatitis A
Active substance: moxifloxacin
J01MA14 Antiinfectives for systemic use | Quinolone antibacterials | Fluoroquinolones
Indicated for: bacterial infections
Active substance: moxifloxacin
J01MA14 Antiinfectives for systemic use | Quinolone antibacterials | Fluoroquinolones
Indicated for: bacterial infections
Active substance: apixaban
Indicated for: prevention and treatment of thromboembolism
Active substance: apixaban
Indicated for: prevention and treatment of thromboembolism
Active substance: dutasteride
Indicated for: benign prostatic hyperplasia
Active substance: interferon beta 1A
Indicated for: multiple sclerosis
Active substance: interferon beta 1A
Indicated for: multiple sclerosis
Active substance: interferon beta 1A
Indicated for: multiple sclerosis
Active substance: interferon beta 1A
Indicated for: multiple sclerosis
Active substance: interferon beta 1A
Indicated for: multiple sclerosis
Active substance: frovatriptan
N02CC07 Nervous system | Antimigraine preparations | Selective serotonin (5HT1) agonists
Indicated for: migraine
Active substance: tocilizumab
Indicated for: autoimmune inflammatory diseases
Active substance: tocilizumab
Indicated for: autoimmune inflammatory diseases
Active substance: tocilizumab
Indicated for: autoimmune inflammatory diseases
Active substance: tocilizumab
Indicated for: autoimmune inflammatory diseases
Active substance: tocilizumab
Indicated for: autoimmune inflammatory diseases
Active substance: bupropion
N06AX12 Nervous system | Antidepressants | Other antidepressants
Indicated for: depression; smoking cessation
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.